Phenylpropanolamine and Associated Myocardial Injury

We report the cases of two patients without significant past medical history in whom developed myocardial injury attributed to the use of anorectic agents containing phenylpropanolamine. The pharmacologic properties of phenylpropanolamine and the current management of common adverse reactions to phenylpropanolamine are briefly reviewed. [Leo PJ, Hollander JE, Shih RD, Marcus SM: Phenylpropanolamine and associated myocardial injury. Ann Emerg Med September 1996;28:359-362.]